Monthly Archives: September 2005

Featured Stories

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

DeflateGate’s Effects Impact Legal Gambling & the Economy

DeflateGate’s-Effects-Impact-Legal-Gambling-and-the-Economy

The NFL has initiated a probe into the New England Patriots following allegations that the team intentionally used overly deflated footballs.

Read More

Pennsylvania Health System Proposes Comprehensive Fracking Study

A proposed study would examine the health effects of hydraulic fracturing (fracking) drilling on the people living closest to active natural gas wells.

Read More

Study Linking Z-Pak to Increased Death Risk Being Reviewed by FDA

The U.S. Food & Drug Administration (FDA) is reviewing a new study that reported an increased risk of sudden, heart-related deaths among people using the antibiotic Zithromax (azithromycin), known popularly as Z-Pak. In a statement issued late yesterday, the FDA said patients being treated with Zithromax should not stop taking ...

Read More

Image Source: wisegeek.com

Trial over Ethicon Transvaginal Mesh Begins in California

Pelvic mesh devices have become the subject of safety concerns in recent years amidst reports that they can cause serious, sometimes permanent injuries.

Read More

First Bard Avaulta Transvaginal Mesh Lawsuit Scheduled for February Trial in MDL

The first test trials in the federal C.R. Bard Avaulta transvaginal mesh litigation will most likely start next year, according to a report from Bloomberg News. About 600 lawsuits involving Bard Avaulta transvaginal mesh products are currently pending in the multidistrict litigation underway Charleston, West Virginia. U.S. District Judge Joseph ...

Read More

Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks

According to a new study, failing metal-on-metal hip implants generate toxic nano-particles that release Cobalt 2+ ions, which not only cause inflammation in surrounding tissue, but have the potential to cause long-term damage to the genetic material of cells. According to a report published by Medicalxpress.com, this “genotoxicity” could ...

Read More

Johnson & Johnson’s Ethicon Division to End Sales of Gynecare Prolift, Three Other Transvaginal Mesh Devices

Johnson & Johnson’s Ethicon Inc. division revealed yesterday that it will end sales of its Gynecare Prolift device and three other transvaginal mesh products. The plan to stop selling the four products was set forth in a letter filed by the company in the Ethicon transvaginal mesh multidistrict litigation ...

Read More

Study Suggests Hormonal Contraceptives Linked to Brain Tumor

Study Suggests Hormonal Contraceptives Linked to Increased Brain Tumor Risk

A study of Danish women of reproductive age suggests that long-term use of hormonal contraceptives is associated with an increased risk of brain tumors.

Read More

Influenza Pandemic a Brewing Storm

There will definitely be another influenza pandemic and no government can afford to be caught off-guard, according to World Health Organization (WHO) Director-General Dr. Lee Jong-wook. Speaking to ministers of health from throughout the Americas at the Pan American Health … Continue reading

Posted in Legal News |

Congress Calls for Investigation into FDA Chiefís Sudden Resignation

Both sides of Capitol Hill are asking questions about the unexpected departure of FDA Commissioner Dr. Lester Crawford.  Crawford stepped down from the FDA’s top post on September 23rd, just two months after a heated confirmation battle in the Senate.  … Continue reading

Posted in Legal News |

Class-Action by Consumer Groups Alleges Pfizer Engaged in a Misleading Advertising Campaign to Boost Lipitor Sales

In the world of prescription drugs, Lipitor is the king with over $10 billion in annual sales. Some consumer groups, however, believe that the drug’s manufacturer, Pfizer Inc., engaged in deceptive advertising of the cholesterol drug in order to boost … Continue reading

Posted in Legal News |

Guidantís Troubles Continue to Grow

Criminal investigators at the U.S. Food and Drug Administration have joined the agency’s probe into how Guidant Corporation handled problems with its heart devices, according to Thursday’s New York Times. The FDA has been looking more closely at Guidant’s products, … Continue reading

Posted in Defective Products |

ADHD Drug, Straterra, May Cause Suicidal Thoughts

Eli Lilly & Company is warning that its ADHD drug, Straterra, may cause suicidal thoughts in children and adolescents.  In a press release dated today, Lilly reported that its Straterra clinical trials database had identified a small but statistically significant … Continue reading

Posted in Legal News |

Vioxx Plaintiff Takes the Stand in New Jersey Trial

Frederick “Mike” Humeston, a 60-year-old Idaho postal worker who suffered a heart attack while taking Vioxx, is suing Merck, contending that the drug maker hid Vioxx’s risks in an effort to preserve sales.  He took the stand Wednesday in the … Continue reading

Posted in Legal News |

Refrigerators and Upright Freezers Recalled Due to Shock Hazard

The U.S. Consumer Product Safety Commission announced the recall of approximately 112,000 Automatic Defrost Upright Freezers and Refrigerators manufactured by WC Wood Company between September 2002 and February 2004.  These units were sold at home improvement and appliance stores between … Continue reading

Posted in Defective Products |

AstraZeneca Reports TOPROL-XL Medication Errors

Users of the beta blocker TOPROL-XL, taken for the treatment of conditions such as hypertension and angina pectoris, need to insure that they are receiving the correct medicine from their doctors and pharmacists.  The Food and Drug Administration (FDA), along … Continue reading

Posted in Health Concerns |

Paxil May Cause Birth Defects

GlaxoSmithKline (GSK) and the Food and Drug Administration (FDA) notified physicians yesterday that PAXIL and PAXIL CR (paroxetine HCI) may be linked to a higher rate of birth defects than currently found with similar drugs. GSK recently conducted a retrospective … Continue reading

Posted in Legal News |

Panic Disorder Increases the Risk of Heart Disease

According to a study in the current issue of Psychosomatic Medicine, people with panic disorder are at double the normal risk for coronary heart disease.  If an individual is also diagnosed with depression, the risk triples. Published in the current … Continue reading

Posted in Health Concerns |

© 2005-2020 Parker Waichman LLP ®. All Rights Reserved.